Clinical Trial for Narcolepsy to Study Once-Nightly Sodium Oxybate

If you or a loved one are over 16 and have been diagnosed with narcolepsy, you may qualify for a research study.

Managing narcolepsy symptoms can be challenging, so learning about treatment options is very important. One option to consider is a research study of an investigational medicine, FT218, which is a once-nightly formulation of sodium oxybate.


In this study, FT218 will be taken orally once per night by qualified patients, before going to bed, for up to two years. Patients will be asked to complete in-person or virtual study visits about four times per year and also complete some brief questionnaires.

You may qualify for participation if you:
  • Are 16 years of age or older
  • Are diagnosed with narcolepsy with or without cataplexy
  • Have completed the REST-ON Study and/or are receiving twice-nightly sodium oxybate
You may not qualify for participation if you:
  • Are on the following medications:
    • Anticonvulsants, clonidine, hypnotics, anxiolytics, sedating antihistamines, antipsychotics, other experimental medications designed to treat narcolepsy, cataplexy or any other sleep condition, or other medications with significant sedating effects/CNS depressant effects
What is Narcolepsy?

Narcolepsy is a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep. People with narcolepsy often find it difficult to stay awake for long periods of time, regardless of the circumstances.

See if You Qualify

What is a Clinical Trial?

A clinical research trial tests the safety and effectiveness of a new medicine or treatment in a population of volunteers. Every medical breakthrough goes through the clinical trial process. Therefore, participants like you play a very important role in advancing medicine for present and future generations.

Intrepid Research

4421 Eastgate Boulevard, Suite 200

Cincinnati, OH 45245